Cytomegalovirus retinitis, in a diabetic immunocompetent patient, after intravitreal ranibizumab injection

2Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We here report a case of cytomegalovirus retinitis in a diabetic patient that occurred after intravitreal ranibizumab injection. A 75-year-old woman was treated with intravitreal ranibizumab injections for diabetic macular edema. During this period, a retinitis occurred in her left eye along with increased IgG and later IgM cytomegalovirus antibody titers. Ocular and intravenous ganciclovir was administered. Cytomegalovirus retinitis subsided post treatment with residual areas of retinal atrophy. Ophthalmologists should be aware of the incidence of cytomegalovirus retinitis, in diabetic patients, after ranibizumab injection.

Cite

CITATION STYLE

APA

Zafeiropoulos, P., Tamboura, P., Dimou, M., Christodoulou, E., & Stefaniotou, M. (2019). Cytomegalovirus retinitis, in a diabetic immunocompetent patient, after intravitreal ranibizumab injection. European Journal of Ophthalmology, 29(1), NP10–NP12. https://doi.org/10.1177/1120672118772525

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free